Approved Study Database

Ref. No. Scientific Title Principal investigator
2021.577 Characterization of the skin, nasal, and gut microbiome associated with Candida auris colonization Dr. LAI Christopher Koon Chi
2016.538 A Comparison of Major Trauma Care in Hong Kong and Germany Dr. LAI Chun Yu
黎鎮宇
2013.034 A retrospective study evaluating C-reactive protein as one of the predictive factors of complicated acute appendicitis Dr Lai Chun Yu
2022.257 Retrospective cohort proof-of-concept study using three-dimensional (3D) histology to better predict oncological outcomes for pT1/2 colorectal adenocarcinomas. Prof. LAI Hei Ming
黎曦明
2025.582 Territorial big data analysis of clinicopathological parameters and clinical diagnosis, outcomes and epidemiological trends in human neoplasms Dr. LAI Hei Ming
2025.069 Applying 3D tissue imaging in diagnosis and theragnosis of urological neoplasms Dr. LAI Hei Ming
Hei Ming Lai
2025.005 Retrospective Analysis of Alirocumab and Evolocumab Therapy in Chinese Population: Prescribing Patterns, Adherence, and Patient Outcomes. Mr. LAI Hiu Chi
2013.337 Role of encircling scleral buckle in management of proliferative vitreoretinopathy Dr Lai Hiu Ping
2024.421 Validation of a breath-based test in predicting response of carvedilol in patients with compensated advanced chronic liver disease Dr. Lai Jimmy Che To
2025.246 Role of minimally invasive tests in predicting clinically significant portal hypertension in patients with unresectable hepatocellular carcinoma Prof. LAI Jimmy Che To
Lai Che To
2025.611 AFFIRM: A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis Prof. Lai Jimmy Che To
2023.521 Baveno VII criteria-guided initiation of non-selective beta blocker in patients with compensated advanced chronic liver disease to reduce hepatic decompensation: an open-label randomised controlled trial Dr. LAI Jimmy Che To
2020.644 Durability of Peginterferon alfa-2b treatment matched with entecavir treatment for HBeAg-positive chronic hepatitis B – a 15-year longitudinal study Dr. LAI Jimmy Che To
黎梓滔
2023.572 Short-term Effect of Podiatric Callus Debridement on Plantar Pressure in Diabetic Neuropathic Patients Miss. LAI Joanne Tze Yan
黎芷茵
2024.561 The Effectiveness of Ankle Taping in Dancers with Chronic Ankle Instability Dr. LAI Jojo Hoi Ching
2018.460 Why AED Consultation Instead of Other Primary Healthcare Settings? A Study on “Relationship between Utilization of Accident & Emergency Department and Other Primary Healthcare Settings” Mr LAI KA WING
黎嘉榮
2018.003 Does autism spectrum disorder (ASD) with comorbid gastrointestinal (GI) symptoms constitute a specific subtype of ASD in terms of genetic mutations? Prof. LAI Kelly Yee Ching
黎以菁
2018.402 Evaluation of Service for Phase 3 of the Student Mental Health Support Scheme Prof. LAI Kelly Yee Ching
黎以菁
2008.119 A Medium Term Follow Up Study on Chinese Adolescents with Anorexia Nervosa in Hong Kong Prof Lai Kelly Yee Ching
2014.033 A Case-control Validation Study of the Cantonese Version of Autism Diagnostic Interview-Revised (ADI-R) on DSM-5 Framework: Test of Inter-rater Consistency, Sensitivity, Specificity and Comparisons between Pre-adolescents with Autism Spectrum Disorder, with Attention Deficit/Hyperactivity Disorder and without Psychiatric Conditions Prof. LAI Kelly Yee Ching
2014.035 A case-control optical imaging study targetting on the functional brain networks related to social communication and repetitive behaviors in Autism Spectrum Disorder (ASD): Comparison and correlation between diagnoses, symptoms and brain signals in a sample of pre-adolescents with Autism Spectrum Disorder, with Attention Deficit/Hyperactivity Disorder and without Psychiatric Conditions Prof. LAI Kelly Yee Ching
2016.502 Social behaviour in patients with APC gene mutation Prof. LAI Kelly Yee Ching
黎以菁
2015.217 Does autism spectrum disorder (ASD) with comorbid gastrointestinal (GI) symptoms constitute a specific subtype of ASD in terms of genetic mutations? Prof. LAI Kelly Yee Ching
黎以菁
2017.126 Evaluation of Service for Student Mental Health Support Scheme Prof. LAI Kelly Yee Ching
黎以菁
2023.529 Orbital RadiothErapy, Sirolimus and Intravenous steroid for Primary Diplopia in Thyroid Eye Disease (RESIDE): a multi-center, double-masked, sham- and placebo-controlled randomized trial Dr. Lai Kenneth Ka Hei
2018.163 Acute Drop in Haemoglobin Level after Hip Fracture Surgery Dr. LAI King Son
黎敬新
2014.231 Retrospective Review of Dementia Patients in a Local Neuro-cognitive Clinic Dr. LAI King Son
2025.855 Evaluating the Clinical Feasibility and Efficacy of Two-Nurse Skin Assessment and Reactive Air Mattress Overlay Interventions on Preventing Hospital-Acquired Pressure Injuries: A Pilot Randomized Controlled Trial in Acute Medical Wards Ms. Lai Kit Ting
2011.376 Observational study on the preference of nasal tip bifidity in Asians Dr Lai Kwong Lun
2010.244 Retrospective Study on Long-term Outcome of Patients with ObscureGastrointestinal Bleeding after Capsule Endoscopy Dr Lai Larry
2014.346 Preference of method of cancer screening comparing exhale breath testing versus blood taking method – A COMPANION STUDY TO A Pilot Study on Cancer Prognosis Using Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) of Breath Tests Ms. LAI Maria Ming Po
2009.398 A Phase III randomized, double-blind, placebo-controlled study of sorafenib as adjuvant treatment for hepatocellular carcinoma after surgical resection or local ablation Prof. Lai Paul B.S.
2009.036 Hypoxia-inducible factor-1 alpha and hepatitis B virus X gene mutants in hepatocellular carcinoma Prof. Lai Paul B.S.
2020.178 Asia-Pacific Multi-Center Randomized Trial of Laparoscopic versus Open Major Hepatectomy for Hepatocellular Carcinoma (AP-LAPO Trial) Prof. LAI Paul B.S.
2007.448 A Prospective, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, International Multicentre Phase III Trial of PI-88 in the Adjuvant Treatment of Post-Resection Hepatocellular Carcinoma (PATHWAY) Professor Lai Paul Bo San
2015.154 Cellular mechanism for reduced expression of the enzyme cytochrome P450 1A2 (CYP1A2) in hepatocellular carcinoma Prof. LAI Paul Bo San
賴寶山
2011.355 A Questionnaire on Understanding and Awareness of the Disease for Patients with Primary Liver Cancer Professor Lai Paul Bo San
2019.340 The use of Surgical Procedure Manager (SPM) application in the operating room - a pilot study Prof. LAI Paul Bo San
2008.070 Response of Hepatocellular Carcinoma Cells at Different Phases of Cell Cycle to Apoptosis Induction by Bid and Chemotherapeutic Agents Prof Lai Paul BS
2017.506 Epidemiology and Risk factors of Hepatitis B/ Hepatitis D co-infection in Hong Kong, A Multicentre Study in Year 2000-2016 Dr. LAI Paul Pok Ho
2008.553 Effect of anticipation on Knee Kinematric during Cutting and Jumping Maneuvers in Healthy Male Individuals Ms Lai Pik Kwan
2026.624 Speech Perception and Cortical Language Processing in Cantonese–English Bilingual Children Dr. Lai Regine
2009.040 Genetic analysis of Chinese patients with Exudative or Hemorrhagic Maculopathy Dr. LAI Timothy
2021.576 A PHASE IIIB, MULTICENTER, RANDOMIZED, VISUAL ASSESSOR-MASKED STUDY OF THE EFFECTIVENESS AND SAFETY OF A 36-WEEK REFILL REGIMEN FOR THE PORT DELIVERY SYSTEM WITH RANIBIZUMAB VS. AFLIBERCEPT TREAT AND EXTEND IN SUBJECTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (DIAGRID) Prof. LAI Timothy Yuk Yau
賴旭佑 教授
2008.051 A Randomized Controlled Trial of Intravitreal Bevacizumab versus Combined Photodynamic Therapy with Verteporfin and Intravitreal Bevacizumab for the Treatment of Choroidal Neovascularization in Pathologic Myopia Dr Lai Timothy Yuk Yau
2009.163 A Phase 2, Randomized, Double-Masked, Placebo-Controlled Study of the Safety, Pharmacokinetics and Biological Effects of Intravenous Fosbretabulin in Asian Subjects with Polypoidal Choroidal Vasculopathy (PCV) Dr. Lai Timothy Yuk Yau
2022.157 Examining the health impact of extreme hot weather on older adults who are in socioeconomic disadvantage and those who are in long-term institutional care in Hong Kong Dr. LAI Tsz Chun
黎子俊
2005.083 Family Experiences in the Decision-Making of Life-Sustaining Treatment Limitation in Intensive Care Setting LAI Vivian Suk Tak
2012.078 A retrospective study: for patient with paracetamol related poisoning, what are the independent predictors for patient's hospital length of stay? Miss Lai Wai Ching
2013.610 Incidence of diabetic retinopathy in Hong Kong ( A retrospective cohort study) Ms Lai Wai Ling

Page 125 of 289.